Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"...
Pain marks the second therapeutic area for Cullgen’s lead protein degrader CG001419SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cullgen...
FORT LAUDERDALE, Fla., Jan. 22, 2025 /PRNewswire/ -- The distinguished and high-profile program Empowered, hosted by Meg Ryan, is proud...
TAMPA, FLORIDA / ACCESS Newswire / January 21, 2025 / Black Book Research, a leading independent market research firm in...
FRAMINGHAM, MA / ACCESS Newswire / January 21, 2025 / New Horizons Medical (NHM), a leader in healthcare for dually...
Established Program Broadens Its Range of Services to Meet the Growing Demand for High-Quality Substance Use Disorder and Mental Health...
SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Adaptive Research Inc. announced that Prodigy Psychiatric Group has joined its clinical...
-- Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer -- -- Key additions expected to...
NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Report on how AI is driving market transformation - The global telerehabilitation systems...
Toronto, Ontario--(Newsfile Corp. - January 20, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"...
NEW ORLEANS, LOUISIANA / ACCESS Newswire / January 17, 2025 / We are excited to announce the arrival of Sober...
84% of behavioral health leaders believe technology can cut relapse rates amid ongoing staffing challenges MIAMI, Jan. 16, 2025 /PRNewswire/...
LAS VEGAS, Jan. 15, 2025 /PRNewswire/ -- Informa Connect announces a landmark collaboration with Behavioral Health Tech to present the...
The Company's natural psilocybin extract powers a culturally transformative study to address methamphetamine addiction through indigenous frameworks.Vancouver, British Columbia--(Newsfile Corp....
New Directors Bring Extensive Leadership Experience in Corporate Strategy and CommercializationSEATTLE and VANCOUVER, British Columbia, Jan. 10, 2025 (GLOBE NEWSWIRE)...
Company also reports preliminary unaudited 2024 revenue of $701.0 millionPARSIPPANY, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc....
~ FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for...
PhenQ is a natural weight management system that targets five major areas of metabolic health, providing a holistic solution for...
Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription...
Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement...